Seroincidence of SARS-CoV-2 infection prior to and during the rollout of vaccines in a community-based prospective cohort of U.S. adults
View ORCID ProfileDenis Nash, Avantika Srivastava, Jenny Shen, Kate Penrose, Sarah Gorrell Kulkarni, Rebecca Zimba, View ORCID ProfileWilliam You, Amanda Berry, Chloe Mirzayi, Andrew Maroko, Angela M. Parcesepe, Christian Grov, View ORCID ProfileMcKaylee M. Robertson
doi: https://doi.org/10.1101/2023.09.29.23296142
Denis Nash
1Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY); New York, New York, USA
2Department of Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy, City University of New York (CUNY); New York, New York, USA
Avantika Srivastava
1Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY); New York, New York, USA
2Department of Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy, City University of New York (CUNY); New York, New York, USA
Jenny Shen
1Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY); New York, New York, USA
2Department of Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy, City University of New York (CUNY); New York, New York, USA
Kate Penrose
1Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY); New York, New York, USA
Sarah Gorrell Kulkarni
1Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY); New York, New York, USA
Rebecca Zimba
1Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY); New York, New York, USA
2Department of Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy, City University of New York (CUNY); New York, New York, USA
William You
1Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY); New York, New York, USA
Amanda Berry
1Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY); New York, New York, USA
Chloe Mirzayi
1Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY); New York, New York, USA
2Department of Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy, City University of New York (CUNY); New York, New York, USA
Andrew Maroko
1Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY); New York, New York, USA
3Department of Environmental, Occupational, and Geospatial Health Sciences, Graduate School of Public Health and Health Policy, City University of New York (CUNY); New York, New York, USA
Angela M. Parcesepe
1Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY); New York, New York, USA
4Department of Maternal and Child Health, Gillings School of Public Health, University of North Carolina, Chapel Hill, North Carolina, USA
5Carolina Population Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
Christian Grov
1Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY); New York, New York, USA
6Department of Community Health and Social Sciences, Graduate School of Public Health and Health Policy, City University of New York (CUNY); New York, New York, USA
McKaylee M. Robertson
1Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY); New York, New York, USA
Article usage
Posted October 02, 2023.
Seroincidence of SARS-CoV-2 infection prior to and during the rollout of vaccines in a community-based prospective cohort of U.S. adults
Denis Nash, Avantika Srivastava, Jenny Shen, Kate Penrose, Sarah Gorrell Kulkarni, Rebecca Zimba, William You, Amanda Berry, Chloe Mirzayi, Andrew Maroko, Angela M. Parcesepe, Christian Grov, McKaylee M. Robertson
medRxiv 2023.09.29.23296142; doi: https://doi.org/10.1101/2023.09.29.23296142
Seroincidence of SARS-CoV-2 infection prior to and during the rollout of vaccines in a community-based prospective cohort of U.S. adults
Denis Nash, Avantika Srivastava, Jenny Shen, Kate Penrose, Sarah Gorrell Kulkarni, Rebecca Zimba, William You, Amanda Berry, Chloe Mirzayi, Andrew Maroko, Angela M. Parcesepe, Christian Grov, McKaylee M. Robertson
medRxiv 2023.09.29.23296142; doi: https://doi.org/10.1101/2023.09.29.23296142
Subject Area
Subject Areas
- Addiction Medicine (396)
- Allergy and Immunology (708)
- Anesthesia (199)
- Cardiovascular Medicine (2909)
- Dermatology (249)
- Emergency Medicine (437)
- Epidemiology (12683)
- Forensic Medicine (10)
- Gastroenterology (824)
- Genetic and Genomic Medicine (4542)
- Geriatric Medicine (413)
- Health Economics (723)
- Health Informatics (2898)
- Health Policy (1066)
- Hematology (383)
- HIV/AIDS (919)
- Medical Education (422)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4305)
- Nursing (233)
- Nutrition (633)
- Oncology (2251)
- Ophthalmology (640)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (276)
- Palliative Medicine (83)
- Pathology (496)
- Pediatrics (1192)
- Primary Care Research (492)
- Public and Global Health (6889)
- Radiology and Imaging (1518)
- Respiratory Medicine (912)
- Rheumatology (433)
- Sports Medicine (381)
- Surgery (482)
- Toxicology (60)
- Transplantation (208)
- Urology (178)